Edition:
United Kingdom

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

2.50USD
23 Aug 2019
Change (% chg)

$-0.07 (-2.72%)
Prev Close
$2.57
Open
$2.56
Day's High
$2.68
Day's Low
$2.49
Volume
421,760
Avg. Vol
551,667
52-wk High
$9.94
52-wk Low
$2.49

About

BioCryst Pharmaceuticals, Inc. is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on the treatment of rare diseases. It uses X-ray crystallography, computer modeling of molecular structures and chemistry... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $346.38
Shares Outstanding(Mil.): 110.31
Dividend: --
Yield (%): --

Financials

  BCRX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.00 -- --
ROI: -136.54 7.52 12.69
ROE: -251.96 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates